New Indications and Dosage Forms for 2002

See also: New Drug Approvals for 2002

August 29, 2002

Lexapro Approved as Maintenance Treatment for Major Depressive Disorder

December 2, 2002

Lexapro Oral Solution Formulation Provides New Option for Depressed Patients

December 18, 2002

Lexapro Receives FDA Approval for the Treatment of Generalized Anxiety Disorder

New indications and dosage forms archive

Recently Approved

Atzumi
Atzumi (dihydroergotamine mesylate) is a nasal powder formulation of the...
Zevaskyn
Zevaskyn (prademagene zamikeracel) is an autologous, cell sheet-based gene...
Imaavy
Imaavy (nipocalimab-aahu) is a neonatal Fc receptor (FcRn) blocker used for the...

More drug approvals